NUKARIO Trademark

Trademark Overview

On Thursday, April 27, 2023, a trademark application was filed for NUKARIO with the United States Patent and Trademark Office. The USPTO has given the NUKARIO trademark a serial number of 97910214. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, January 23, 2025. This trademark is owned by Genzyme Corporation. The NUKARIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Alzheimer's
nukario

General Information

Serial Number97910214
Word MarkNUKARIO
Filing DateThursday, April 27, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, January 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutical preparations for the treatment of central nervous system diseases and disorders, pharmaceutical preparations for the treatment of Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Alzheimer's

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events

Event DateEvent Description
Wednesday, May 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 1, 2023NEW APPLICATION ENTERED
Friday, May 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 23, 2023ASSIGNED TO EXAMINER
Wednesday, May 24, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 24, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, June 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 23, 2024SOU EXTENSION 1 FILED
Tuesday, January 23, 2024SOU EXTENSION 1 GRANTED
Thursday, January 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2024SOU EXTENSION 2 FILED
Thursday, January 23, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 23, 2025SOU EXTENSION 3 FILED
Friday, January 24, 2025SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 3, 2024SOU EXTENSION 2 GRANTED

Related Keywords

nukario treatment pharmaceutical diseases preparations sclerosis amyotrophic lateral alzheimer multiple disorders